Natalya Davies
Stock Analyst at Rothschild & Co Redburn
(3.56)
# 2,218
Out of 5,074 analysts
10
Total ratings
90%
Success rate
22.1%
Average return
Main Sectors:
Stocks Rated by Natalya Davies
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Initiated Coverage: Sell | $1,200 | $1,684.64 | -28.77% | 1 | Sep 2, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €285.00 | €273.50 | +4.20% | 1 | Apr 17, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $179 | $147.24 | +21.57% | 1 | Apr 17, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $160 | $178.71 | -10.47% | 1 | Apr 17, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $575 → $620 | $676.54 | -8.36% | 2 | Apr 17, 2026 | |
| BRKR Bruker | Reiterated: Buy | $60 | $57.31 | +4.69% | 2 | Nov 20, 2025 | |
| A Agilent Technologies | Initiated Coverage: Buy | $165 | $173.89 | n/a | 1 | Oct 8, 2025 | |
| WAT Waters | Initiated Coverage: Buy | $390 | $455.59 | n/a | 1 | Oct 8, 2025 |
Mettler-Toledo International
Sep 2, 2026
Initiated Coverage: Sell
Price Target: $1,200
Current: $1,684.64
Upside: -28.77%
Sartorius Aktiengesellschaft
Apr 17, 2026
Reiterated: Buy
Price Target: €285.00
Current: €273.50
Upside: +4.20%
Merck & Co.
Apr 17, 2026
Reiterated: Buy
Price Target: $179
Current: $147.24
Upside: +21.57%
Repligen
Apr 17, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $178.71
Upside: -10.47%
Thermo Fisher Scientific
Apr 17, 2026
Reiterated: Buy
Price Target: $575 → $620
Current: $676.54
Upside: -8.36%
Bruker
Nov 20, 2025
Reiterated: Buy
Price Target: $60
Current: $57.31
Upside: +4.69%
Agilent Technologies
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $165
Current: $173.89
Upside: n/a
Waters
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $390
Current: $455.59
Upside: n/a